R.N. Laboratories Private Limited - Company Profile

It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 1998.
1998 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About R.N. Laboratories Private Limited

R.N. Laboratories Private Limited, a active private limited company, was established on 04 December 1998 in Mumbai, Maharashtra, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24200MH1998PTC117339. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹9.91 Cr.

Formerly known as Sky Chem Private Limited. It upholds a compliant status. Employing 242 professional, Its leadership includes Vijay Nilkanth Koyande (Director), Rohit Shamlal Garg (Director), Sanket Dhondiraj Sawant (Director). Past directors included Vikram Vyas, Vijay Nilkanth Koyande, Sanket Dhondiraj Sawant. It holds ₹152.00 Cr open charges and ₹38.50 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at A305, Vip Plaza, Off Link Road, Veera Desai Road, Andheri, West,, Mumbai, Maharashtra, 400053.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24200MH1998PTC117339

  • Registration Number

    117339

  • Incorporation Date

    04 December 1998

  • Authorized Capital

    ₹10.00 Cr

  • Paid-Up Capital

    ₹9.91 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 10.00 Cr
  • Paid Up Capital ₹ 9.91 Cr
  • Company Age 27 Year, 6 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 152.00 Cr
  • Satisfied Charges ₹ 38.50 Cr
  • Revenue Growth **** 46.97%
  • Profit Growth **** 428.59%
  • Ebitda **** 821.64%
  • Net Worth 6.33%
  • Total Assets **** 13.96%
Company report

R.N. Laboratories Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into R.N. Laboratories Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at R.N. Laboratories Private Limited?
Current Directors
Name Designation Appointment Date Status
Vijay Nilkanth Koyande Director 13 Aug 2025 Current
Rohit Shamlal Garg Director 04 Dec 1998 Current
Sanket Dhondiraj Sawant Director 30 Jul 2021 Current
Nitin Sham Lal Garg Director 04 Dec 1998 Current
Darshan Harish Bhawsar Director 05 Mar 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 29 Aug 2024 Past
Pramod Abcsdd Additional Director 29 Sep 2025 Past
Pramod Abcsdd Additional Director 30 Nov 2021 Past
Pramod Abcsdd Director 27 Dec 2021 Past
Pramod Abcsdd Director 08 Apr 2019 Past
Pramod Abcsdd Additional Director 29 Sep 2025 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of R.N. Laboratories.

R.N. Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 46.97% increase. The company also saw a substantial improvement in profitability, with a 428.59% increase in profit. The company's net worth moved up by a moderate rise of 6.33%.

R.N. Laboratories revenue growth over time
R.N. Laboratories profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 46.97%
*******
*******
*******
*******
Revenue from Operations
*******
 53.71%
*******
*******
*******
*******
Total Assets
*******
 13.96%
*******
*******
*******
*******
Profit or Loss
*******
 428.59%
*******
*******
*******
*******
Net Worth
*******
 6.33%
*******
*******
*******
*******
EBITDA
*******
 821.64%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of R.N. Laboratories?

In 2023, R.N. Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹1,520,000,000.00

Satisfied Charges

₹385,000,000.00

Charges Breakdown by Lending Institutions
  • Citi Bank N.A. : 102.00 Cr
  • Hdfc Bank Limited : 50.00 Cr
Latest Charge Details
Date Lender Amount Status
28 Jun 2023 Hdfc Bank Limited ₹25.00 Cr Open
05 Jan 2023 Hdfc Bank Limited ₹25.00 Cr Open
03 Aug 2019 Citi Bank N.A. ₹60.00 Cr Open
28 Aug 2017 Citi Bank N.A. ₹2.00 Cr Open
30 Dec 2014 Citi Bank N.A. ₹40.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at R.N. Laboratories?

R.N. Laboratories has a workforce of 242 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of R.N. Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped R.N. Laboratories's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on R.N. Laboratories
Recent Activity within the Organization
  • Annual General Meeting

    Progress on R.N. Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Director Appointment

    Vijay Nilkanth Koyande was appointed as a Director was appointed as a Director on 13 Aug 2025 & has been associated with this company since 9 months 30 days . was recorded as a recent event.

  • Balance Sheet

    The activity R.N. Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.

  • Director Appointment

    Progress on Darshan Harish Bhawsar was appointed as a Director was appointed as a Director on 05 Mar 2025 & has been associated with this company since 1 year 3 months . was documented.

  • Charges

    Progress on A charge with Citi Bank N.A. of Rs. 40.00 Cr registered on 30 Dec 2014 with Charge ID 10568036 was modified on 19 Jul 2024. was documented.

  • Charges

    The activity A charge with Citi Bank N.A. of Rs. 60.00 Cr registered on 03 Aug 2019 with Charge ID 100290495 was modified on 20 Jul 2023. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of R.N. Laboratories Private Limited?

The CIN of R.N. Laboratories Private Limited is U24200MH1998PTC117339.

Where is R.N. Laboratories Private Limited headquartered?

R.N. Laboratories Private Limited is headquartered at A305, Vip Plaza, Off Link Road, Veera Desai Road, Andheri, West,, Mumbai, Maharashtra, 400053.

When was R.N. Laboratories Private Limited incorporated?

R.N. Laboratories Private Limited was incorporated on 04 December 1998.

Who are the current directors of R.N. Laboratories Private Limited?

The current directors of R.N. Laboratories Private Limited are

What is the primary industry of R.N. Laboratories Private Limited?

The primary industry of R.N. Laboratories Private Limited is Manufacturing.

Is R.N. Laboratories Private Limited a listed company?

R.N. Laboratories Private Limited is unlisted.

What is the capital structure of R.N. Laboratories Private Limited?

The authorized capital of R.N. Laboratories Private Limited is ₹10.00 Cr, and the paid-up capital is ₹9.91 Cr.

What is the compliance status of R.N. Laboratories Private Limited?

The compliance status of R.N. Laboratories Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available